One of the main ways to improve the outcomes for pancreatic cancer patients is early diagnosis and the way to better diagnostics is through a greater understanding of the initiating […]
UCLA Researchers Receive Over $6M from NIH to Study Potential Immunotherapies for Pancreatic Cancer
Research teams at UCLA have received two grants from the National Institutes of Health (NIH), totaling over $6 million dollars to study the immunobiology of pancreatic tumors and develop a […]
Hirshberg funded UCLA study finds combination therapy suppresses pancreatic tumor growth
UCLA Jonsson Comprehensive Cancer Center researchers, including our Scientific Advisory Board member and close collaborator, Dr. Timothy Donahue have uncovered a therapy that subdues tumor growth. The study, published in […]
Research Identifies Loss of Protein Linking Chronic Pancreatitis to Pancreatic Cancer, May Present New Tailored Therapy
Chronic pancreatitis is a known risk factor for the development of pancreatic cancer. However, the genetic alterations that cause this chronic inflammation and therefore predispose the patient to malignant transformation […]
Key Protein for Pancreatic Cancer Cell Growth Discovered, May Provide Therapeutic Target
Pancreatic cancer is particularly deadly because it is often found in advanced stages when the tumor has grown too large and spread from the pancreas making removal impossible. In order […]
Research Into The Pancreatic Cancer Microenvironment May Provide Novel Treatment Avenues
Pancreatic cancer is one of the most difficult cancers to treat in part because of the poorly understood and complex mechanisms of disease progression. Pancreatic cancer is characterized by the […]